RIGEL PHARMACEUTICALS INC (RIGL) Return on equity 2016–2025
RIGEL PHARMACEUTICALS INC (RIGL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
93.8%FY2025 · since FY2016: -125.8% → 93.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 93.8% | -438.0 pp |
| FY2024 | 531.8% | — |
| FY2021 | -59.0% | +28.4 pp |
| FY2020 | -87.4% | +36.9 pp |
| FY2019 | -124.3% | -60.2 pp |
| FY2018 | -64.1% | +13.3 pp |
| FY2017 | -77.5% | +48.3 pp |
| FY2016 | -125.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice